Effects of single, short term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy

被引:14
作者
Kon, CH
Occleston, NL
Foss, A
Sheridan, C
Aylward, GW
Khaw, PT
机构
[1] Inst Ophthalmol, Dept Pathol, Wound Healing Res Unit, London EC1V 9EL, England
[2] Moorfields Eye Hosp, London EC1V 9EL, England
关键词
D O I
10.1136/bjo.82.5.554
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim-To investigate the effects of single, short term (5 or 30 minutes) exposures to thiotepa or 5-fluorouracil (5-FU) on collagen lattice contraction and retinal pigment epithelial (RPE) cell proliferation. Methods-Far collagen contraction studies, RPE cells seeded into free floating type I collagen lattices were exposed to single 5 or 30 minute treatments with thiotepa (0.06-4 mg/ml), or 5-FU (0.25-25 mg/ml), or phosphate buffered saline alone as a control. For proliferation studies, RPE cell monolayers were similarly exposed to these agents. The degree of contraction, effects on cell number, and viability were determined up to 14 days after treatment. Results-Contraction of collagen lattices containing RPE cells and proliferation of RPE cells were significantly inhibited (p<0.05) by thiotepa and 5-FU at concentrations above 0.06 mg/ml and 0.25 mg/ml respectively (for both 5 and 30 minute treatments), compared with controls. Cell death did not occur except for exposure of the RPE cells in collagen lattices to the highest concentration of thiotepa (4 mg/ ml). Conclusion-It was concluded that single 5 or 30 minute exposures to thiotepa or 5-FU significantly inhibited collagen contraction and the proliferation of RPE cells. These findings suggest that short, single, non-toxic exposures to thiotepa or 5-FU which can be reproduced clinically may be useful in the modulation of proliferative vitreoretinopathy.
引用
收藏
页码:554 / 560
页数:7
相关论文
共 23 条
[1]  
BARRADA A, 1984, OPHTHALMIC SURG LAS, V15, P767
[2]   SELECTION OF THERAPEUTIC AGENTS FOR INTRAOCULAR PROLIFERATIVE DISEASE .2. DIFFERING ANTIPROLIFERATIVE ACTIVITY OF THE FLUOROPYRIMIDINES [J].
BLUMENKRANZ, MS ;
HARTZER, MK ;
HAJEK, AS .
ARCHIVES OF OPHTHALMOLOGY, 1987, 105 (03) :396-399
[3]   FLUOROURACIL FOR THE TREATMENT OF MASSIVE PERIRETINAL PROLIFERATION [J].
BLUMENKRANZ, MS ;
OPHIR, A ;
CLAFLIN, AJ ;
HAJEK, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (04) :458-467
[4]  
EDWARDS RB, 1982, METHOD ENZYMOL, V81, P39
[5]  
EHRLICH D, 1977, OPHTHALMIC SURG LAS, V8, P23
[6]  
ERICSON L, 1964, ACTA OPHTHALMOL, V42, P721
[7]  
ERICSON LA, 1961, ACTA OPHTHALMOL, V39, P569
[8]   SELECTION OF THERAPEUTIC AGENTS FOR INTRAOCULAR PROLIFERATIVE DISEASE .3. EFFECTS OF FLUOROPYRIMIDINES ON CELL-MEDIATED CONTRACTION OF HUMAN-FIBROBLASTS [J].
HARTZER, MK ;
BLUMENKRANZ, MS ;
HAJEK, AS ;
DAILEY, WA ;
CHENG, M ;
MARGHERIO, AR .
EXPERIMENTAL EYE RESEARCH, 1989, 48 (03) :321-328
[9]   THE CLASSIFICATION OF RETINAL-DETACHMENT WITH PROLIFERATIVE VITREORETINOPATHY [J].
HILTON, G .
OPHTHALMOLOGY, 1983, 90 (02) :121-125
[10]   RETINAL-PIGMENT EPITHELIAL-CELLS IN EPIRETINAL MEMBRANES - AN IMMUNOHISTOCHEMICAL STUDY [J].
HISCOTT, PS ;
GRIERSON, I ;
MCLEOD, D .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1984, 68 (10) :708-715